New data on postbiotic LactoSporin shows anti-acne and anti-aging benefits

By Deanna Utroske

- Last updated on GMT

© Getty Images \ (gorodenkoff)
© Getty Images \ (gorodenkoff)

Related tags microbiome postbiotics Acne Protection

Sabinsa makes specialty ingredients for the food, pharma, and beauty industries. In early 2019, the company launched LactoSporin into the realm of microbiome skin care. Now this year, the company has published data pointing too additional skin care benefits.

The ingredient, known by the INCI name Bacillus Ferment Filtrate Extract, is extracted from the liquid surrounding the cultured lactic acid-forming bacterial species B. coagulans. Sabinsa uses a patented extraction process as is so often the case in beauty ingredient production.

In fact, the press release issued when the ingredient was first launched in March of 2019 noted that LactoSporin has some 12 patents behind it globally in countries including the US, Canada, Japan, South Korea, Australia, New Zealand, and beyond.

At that time, Sabina highlighted the antioxidant activity of LactoSporin as well as the ingredient’s anti-inflammatory and anti-collagenase activity (collagenase refers to the breaking of bonds within collagen molecules).

Sabinsa Founder Dr Muhammed Majeed was quoted in the that March 2019 press release saying, “The diverse applications of LactoSporin are exciting, and as our research continues, we see even more opportunities ahead.”

Sabina publishes microbiome beauty data in the MDPI journal Cosmetics

In two separate articles published this year in the peer-reviewed open-access journal Cosmetics, Sabinsa share information from studies looking at the efficacy, tolerability, and safety of LactoSporin as a topical acne treatment and as a skin protection ingredient.

Commenting on the acne treatment study—published in Cosmetics as Novel Topical Application of a Postbiotic, LactoSporin, in Mild to Moderate Acne: A Randomized, Comparative Clinical Study to Evaluate its Efficacy, Tolerability and Safety​—Shaheen Majeed, president Worldwide of Sabinsa and a co-author of the study along with Dr Muhammed Majeed and several other researchers, says, “The emerging field of postbiotics continues to garner interest from the scientific community, and this is an area of immense interest to Sabinsa as well.”

“Here we introduced, LactoSporin, a metabolic byproduct of our probiotic, to help improve the composition of the skin’s beneficial bacteria. This study clearly shows that LactoSporin is highly suitable for treating subjects with mild-to-moderate acne vulgaris,” ​he says in a recent press release from the ingredient maker.

The other newly published article suggesting antiaging and/or skin protective benefits is titled Skin Protective Activity of LactoSporin-the Extracellular Metabolite from Bacillus Coagulans MTCC 5856​. And as the company’s release explains, “the anti-acne effects of LactoSporin were observed as early as three days.”

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers